Swift and accurate results provide benefits to your hospital and your patients.
The costs of healthcare for patients with resistant infections is much higher than care for patients with non-resistant infections, due to longer duration of illness, isolation requirements, additional tests and use of more expensive drugs.
The benefits of rapid AMR surveillance can easily outweigh additional screening costs, due to
- fast patient release from pre-emptive isolation;
- fast reopening of blocked wards;
- reduction of excess costs caused by CPO infections, by lowering hospital transmission.
Fast diagnosis of AMR prevents infection outbreaks, reduces costs and saves lives.